This special lung issue of the Chinese Clinical Oncology (CCO) is reporting the last Franco-Chinese symposium in Guangzhou, gathering the experts of Sun Yat Sen hospital (Pro Lanjun Zhang and Li Zhang), Gustave Roussy Institute and Marie-Lannelongue Hospital in Paris (Dr Ju Liya).
It does cover the best of local and stereotactic radiotherapy, extended local surgery, tyrosine kinase therapy and the late but promising immunotherapy approach. The lung conference did aim at gathering distinguished researchers, clinicians, working in the field of lung cancer therapeutics. The CCO journal has already published papers of the Chinese experts in the field. This special issue will offer the French add value to the Chinese oncology community.
Figure 1：Jean-Pierre Armand, MD, MSc.
Senior Consultant, Department of innovative therapeutic, Gustave Roussy Insititute, Grand Paris Cancer Campus, Paris, France.
Figure 2：Liya Ju, MD, PhD.
Laboratoire Jean Dausset, Histocompatibility and Immunology, Saint-Louis Hospital, Paris, France.